Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Probi: A true pioneer in probiotic research is elected NutraChampion 2020

ProbiRegulatory press release14.05.2020 klo 12.00
Read the release

Bengt Jeppsson, one of the founders of Probi[®], elected NutraChampion winner

Yesterday, Dr. Bengt Jeppsson was selected as the winner of the new NutraChampion category of Nutra Ingredients Awards. The jury's selection was judged as "An important and lasting contribution to our industry and the wider causes of public health and nutrition, this award celebrates long-term and high-level personal achievements that have driven change within the science and business of our industry".

"It all started with a vision of saving lives" is the opening sentence often used by Professor Jeppsson when talking about his discovery of the probiotic bacteria Lactobacillus plantarum 299v (LP299V[®]).

Bengt Jeppsson, Professor and Medical Doctor, was Sweden's first probiotic pioneer and one of the very first scientists to go beyond standard medical treatments.

Dr Jeppsson began his work at Lund University Hospital in Sweden, in the 1980s. He identified a huge problem: patients in the intensive care unit (ICU) often suffered from sepsis and major organ failure during recovery. Collaborative research led by Dr Jeppsson discovered one of today's most researched probiotic bacteria, LP299V[®], and its important role in promoting gastrointestinal health in persons who need it the most. The initial studies on the LP299V[®] strain showed great support for improved recovery and health.

Since then, the LP299V[®] bacterium has been studied in more than 60 clinical studies and is today one of the leading probiotic strains to support digestive health, sold in more than 40 markets over the world.Bengt Jeppsson remains active as Professor, Medical Doctor and Senior Scientific Advisor at Probi[®] and in regards to the award he comments: "I am very pleased and see the award as an acknowledgement of a lifetime dedication to probiotic research - the award is shared with all the people who made it possible". And Bengt concludes: "My passion is to see how we can use bacteria as friends and not as enemies".

 

FOR FURTHER INFORMATION, CONTACT:

Charlotte Beyerholm, Director Marketing & Global Communication, Probi[®], tel +46 76 870 94 65, e-mail: charlotte.beyerholm@probi.com

ABOUT PROBI

Probi is a world leader within probiotics. Our vision is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Probi offers dedicated probiotic expertise and partnership all the way from R&D to finished products for companies within the consumer healthcare and food industry. Our GMP certified manufacturing facilities produce probiotics in custom made formats with value-adding delivery technologies. Founded by scientists in Sweden 1991, Probi is a multinational company with 4 centers of excellence, active in more than 40 markets around the world and holding over 400 patents worldwide. Read more at www.probi.com.